Skip to Main Content

Author Details

Onyema Ogbuagu
Yale School of Medicine, Yale University
2014
66
14
Wade Schulz (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36890468HIV risk profile and prevention needs of individuals seeking monkeypox (mpox) vaccination in an urban clinic in the U.S.: a brief report.BMC Infect Dis2023
37903581Supporting the Manufacturing of Medical Supplies in Africa: Collaboration Between Africa CDC, Partners, and Member States.Glob Health Sci Pract2023
38058292Pharmacokinetic evaluation of sofosbuvir/velpatasvir for the treatment of Chronic Hepatitis C in pediatrics aged 3 and older.Expert Opin Drug Metab Toxicol2023
37946248Acute cytomegalovirus proctitis and epididymitis acquired via sexual transmission in an immunocompetent patient: a case report.J Med Case Rep2023
37189137A continent-wide effort and solidarity at curbing COVID-19 pandemic: the Africa task force for novel coronavirus (AFTCOR) infection prevention and control technical working group's experience.BMC Public Health2023
37451297Efficacy and safety of the novel capsid inhibitor lenacapavir to treat multidrug-resistant HIV: week 52 results of a phase 2/3 trial.Lancet HIV2023
37046201Correction: HIV risk profile and prevention needs of individuals seeking monkeypox (mpox) vaccination in an urban clinic in the U.S.: a brief report.BMC Infect Dis2023
37101135Outcomes of pregnant women exposed to Sotrovimab for the treatment of COVID-19 in the BA.1 Omicron predominant era (PRESTO).BMC Infect Dis2023
37067160Lenacapavir: a twice-yearly treatment for adults with multidrug-resistant HIV infection and limited treatment options.Expert Rev Anti Infect Ther2023
36963025Transforming medical education in Liberia through an international community of inquiry.PLOS Glob Public Health2023
34632695Qualitative assessment of anti-SARS-CoV-2 spike protein immunogenicity (QUASI) after COVID-19 vaccination in older people living with HIV.HIV Med2022
35703420Early infant diagnosis of HIV infection at the John F. Kennedy Medical Center, Monrovia, Liberia.HIV Res Clin Pract2022
35657826Proactive strategies to optimize engagement of Black, Hispanic/Latinx, transgender, and nonbinary individuals in a trial of a novel agent for HIV pre-exposure prophylaxis (PrEP).PLoS One2022
36578087Acute kidney injury due to myoglobin cast nephropathy in the setting of coronavirus disease 2019-mediated rhabdomyolysis: a case report.J Med Case Rep2022
36131232Long-term quantitative assessment of anti-SARS-CoV-2 spike protein immunogenicity (QUASI) after COVID-19 vaccination in older people living with HIV (PWH).BMC Infect Dis2022
35090638Safety and immunogenicity of an AS03-adjuvanted SARS-CoV-2 recombinant protein vaccine (CoV2 preS dTM) in healthy adults: interim findings from a phase 2, randomised, dose-finding, multicentre study.Lancet Infect Dis2022
35301314De novo emergence of a remdesivir resistance mutation during treatment of persistent SARS-CoV-2 infection in an immunocompromised patient: a case report.Nat Commun2022
34162599Late neurosyphilis and VZV meningoencephalitis coinfection.BMJ Case Rep2021
33542020A new positive SARS-CoV-2 test months after severe COVID-19 illness: reinfection or intermittent viral shedding?BMJ Case Rep2021
34909781<i>De novo</i> emergence of a remdesivir resistance mutation during treatment of persistent SARS-CoV-2 infection in an immunocompromised patient: A case report.medRxiv2021
34900617High HIV Detection in a Tertiary Facility in Liberia: Implications and Opportunities.Ann Glob Health2021
34900615Gaps and Opportunities in HIV Service Delivery in High Volume HIV Care Centers in Liberia: Lessons From the Field.Ann Glob Health2021
34707981Facing COVID-19 in Liberia: Adaptations of the Resilient and Responsive Health Systems Initiative.Ann Glob Health2021
33956849Race and ethnicity do not impact eligibility for remdesivir: A single-center experience.PLoS One2021
34197772Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial.Lancet HIV2021
32821939Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial.JAMA2020
33318281<i>Mycobacterium marinum</i>: nodular hand lesions after a fishing expedition.BMJ Case Rep2020
32863269Transmission risk of respiratory viruses in natural and mechanical ventilation environments: implications for SARS-CoV-2 transmission in Africa.BMJ Glob Health2020
31053098Contemporary HCV pangenotypic DAA treatment protocols are exclusionary to real world HIV-HCV co-infected patients.BMC Infect Dis2019
31645394Successful sofosbuvir lead-in monotherapy for the treatment of hepatitis C virus (HCV) infection in a pregnant woman living with HIV.BMJ Case Rep2019
31749636Dolutegravir And Lamivudine Combination For The Treatment Of HIV-1 Infection.HIV AIDS (Auckl)2019
31890474Preferences for implementation of HIV pre-exposure prophylaxis (PrEP): Results from a survey of primary care providers.Prev Med Rep2019
30145707Prevalence and Correlates of Unhealthy Alcohol and Drug Use Among Men Who Have Sex with Men Prescribed HIV Pre-exposure Prophylaxis in Real-World Clinical Settings.AIDS Behav2019
31412130Implementing a Comprehensive HCV Clinic within an HIV Clinic: A Model of Care for HCV Micro-elimination.Open Forum Infect Dis2019
31407474Mitochondrial DNA somatic mutation burden and heteroplasmy are associated with chronological age, smoking, and HIV infection.Aging Cell2019
30794678Correction: Perceptions of HIV transmission and pre-exposure prophylaxis among health care workers and community members in Rwanda.PLoS One2019
29271660Pegylated interferon alpha 2a for the treatment of hepatitis C virus infection.Expert Opin Drug Metab Toxicol2018
29901657The Changing Face of HIV Care: Expanding HIV Training in an Internal Medicine Residency Program.Acad Med2018
30464642Dolutegravir/rilpivirine for the treatment of HIV-1 infection.HIV AIDS (Auckl)2018
30475841Perceptions of HIV transmission and pre-exposure prophylaxis among health care workers and community members in Rwanda.PLoS One2018
30412140Integrase inhibitor-based regimens result in more rapid virologic suppression rates among treatment-naïve human immunodeficiency virus-infected patients compared to non-nucleoside and protease inhibitor-based regimens in a real-world clinical setting: A retrospective cohort study.Medicine (Baltimore)2018
29527934HIV Risk perception and eligibility for pre-exposure prophylaxis in women involved in the criminal justice system.AIDS Care2018
29780817Clinical Profile and Outcome of Patients with Acute Kidney Injury Requiring Hemodialysis: Two Years' Experience at a Tertiary Hospital in Rwanda.Biomed Res Int2018
29749873Fatal cryptococcal meningitis in an AIDS patient complicated with immune reconstitution syndrome refractory to prolonged amphotericin B treatment.Int J STD AIDS2018
29038191Obstructive uropathy as initial presentation of genitourinary tuberculosis and masquerading as a postsurgical complication.BMJ Case Rep2017
28409656Condomless sex and HIV transmission among serodifferent couples: current evidence and recommendations.Ann Med2017
29180506Answer to December 2017 Photo Quiz.J Clin Microbiol2017
29180502Photo Quiz: Peripheral Blood Smear in a Ugandan Refugee.J Clin Microbiol2017
26769754Steroid-exacerbated HIV-associated cutaneous Kaposi's sarcoma immune reconstitution inflammatory syndrome: 'Where a good intention turns bad'.Int J STD AIDS2016
27797606Rilpivirine, emtricitabine and tenofovir alafenamide: single-tablet combination for the treatment of HIV-1 infection in selected patients.Expert Rev Anti Infect Ther2016
  • 1 - 50 of 66

Recommended Authors

Padua University Hospital
Career Start Year 2016
Number of shared co-authors 0
University of Nebraska Medical Center
Career Start Year 2011
Number of shared co-authors 0
Vanderbilt University Medical Center
Career Start Year 2007
Number of shared co-authors 0
School of Public Health, Brown University
Career Start Year 2007
Number of shared co-authors 0
University of Minnesota
Career Start Year 2003
Number of shared co-authors 1
Goethe University Frankfurt, University Hospital
Career Start Year 2003
Number of shared co-authors 2
Center for Infectious Diseases Research, Walter Reed Army Institute of Research
Career Start Year 2002
Number of shared co-authors 0
McMaster University
Career Start Year 2001
Number of shared co-authors 0
Vitalant Research Institute, USA University of California san francisco
Career Start Year 2001
Number of shared co-authors 1
University of California San Diego
Career Start Year 2001
Number of shared co-authors 3
Lausanne University Hospital, University of Lausanne
Career Start Year 1999
Number of shared co-authors 4
Duke Clinical Research Institute and Duke University School of Medicine
Career Start Year 1998
Number of shared co-authors 1
&quotMagna Graecia&quot University
Career Start Year 1998
Number of shared co-authors 1
Massachusetts General Hospital
Career Start Year 1996
Number of shared co-authors 0
Harvard TH Chan School of Public Health
Career Start Year 1996
Number of shared co-authors 0
Kaiser Permanente San Francisco Medical Center
Career Start Year 1994
Number of shared co-authors 2
Hospital Germans Trias i Pujol
Career Start Year 1992
Number of shared co-authors 1
university of california los angeles Center for Clinical AIDS Research & Education
Career Start Year 1992
Number of shared co-authors 2
Johns Hopkins School of Medicine, Johns Hopkins University
Career Start Year 1990
Number of shared co-authors 2
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1988
Number of shared co-authors 3
University of Cincinnati
Career Start Year 1988
Number of shared co-authors 3
University of Nebraska Medical Center
Career Start Year 1987
Number of shared co-authors 1
IF School of Medicine, University of Pennsylvania
Career Start Year 1987
Number of shared co-authors 2
VA Medical Center
Career Start Year 1986
Number of shared co-authors 0
Global Health Institute, University of Antwerp
Career Start Year 1982
Number of shared co-authors 2
David Geffen School of Medicine, University of California los angeles
Career Start Year 1982
Number of shared co-authors 0
University of Alabama at Birmingham
Career Start Year 1980
Number of shared co-authors 1
IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol
Career Start Year 1979
Number of shared co-authors 1
University of Miami, Miller School of Medicine
Career Start Year 1977
Number of shared co-authors 0
Italian Ministry of Health
Career Start Year 1977
Number of shared co-authors 2

Collaborators

Yale University
Co-authored papers 3
Yale University
Co-authored papers 2
Yale School of Public Health
Co-authored papers 2
Yale University School of Medicine
Co-authored papers 2
Fred Hutchinson Cancer Center
Co-authored papers 2
Yale University
Co-authored papers 2
University of Washington Medical Center
Co-authored papers 2
Instituto Goncalo Moniz, Yale School of Public Health
Co-authored papers 2
Yale University School of Medicine
Co-authored papers 2
Yale University, USA Howard Hughes Medical Institute
Co-authored papers 2
Yale School of Medicine
Co-authored papers 2
Yale University, USA Howard Hughes Medical Institute
Co-authored papers 1
Co-authored papers 1
Virginia Commonwealth University
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Weill Institute for Neurosciences, University of California san francisco
Co-authored papers 1
La Paz University Hospital
Co-authored papers 1
University of British Columbia
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
University of Washington
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Yale School of Medicine
Co-authored papers 1
Beth Israel Deaconess Medical Center
Co-authored papers 1
Co-authored papers 1